OPEN MARKET SALE AGREEMENTOpen Market Sale Agreement • March 7th, 2023 • Verona Pharma PLC • Pharmaceutical preparations • New York
OPEN MARKET SALE AGREEMENTOpen Market Sale Agreement • October 13th, 2016 • National Storage Affiliates Trust • Real estate investment trusts • New York
OPEN MARKET SALE AGREEMENTOpen Market Sale Agreement • August 20th, 2021 • Ardmore Shipping Corp • Deep sea foreign transportation of freight • New York
OPEN MARKET SALE AGREEMENTOpen Market Sale Agreement • September 1st, 2023 • Ardmore Shipping Corp • Deep sea foreign transportation of freight • New York
AMENDMENT NO. 2 TO OPEN MARKET SALE AGREEMENT December 23, 2022Open Market Sale Agreement • December 23rd, 2022 • Sangamo Therapeutics, Inc • Biological products, (no disgnostic substances)
This Amendment No. 2 (“Amendment No. 2”) amends that certain Open Market Sale AgreementSM, dated as of August 5, 2020, as amended by Amendment No. 1 (“Amendment No. 1”) to Open Market Sale AgreementSM, dated as of May 5, 2021 (the “Agreement”), by and between Sangamo Therapeutics, Inc. (the “Company”) and Jefferies LLC, as sales agent and/or principal (the “Agent”). Defined terms used herein and not otherwise defined shall have the meaning assigned to such terms in the Agreement.
AMENDMENT NO. 1 TO OPEN MARKET SALE AGREEMENT March 2, 2020Open Market Sale Agreement • March 2nd, 2020 • Wave Life Sciences Ltd. • Pharmaceutical preparations
This Amendment No. 1 (“Amendment No. 1”) amends that certain Open Market Sale AgreementSM, dated as of May 10, 2019 (the “Agreement”), by and between Wave Life Sciences Ltd. (the “Company”) and Jefferies LLC, as sales agent and/or principal (the “Agent”). Defined terms used herein and not otherwise defined shall have the meaning assigned to such terms in the Agreement.
OPEN MARKET SALE AGREEMENTOpen Market Sale Agreement • August 8th, 2023 • Postal Realty Trust, Inc. • Real estate investment trusts
Reference is made to that certain Open Market Sale Agreement (the “Agreement”), dated as of November 4, 2022, by and between Postal Realty Trust, Inc. (the “Company”), Postal Realty LP (the “Operating Partnership”) and [BANK] (the “Sales Agent”). Capitalized terms used but not defined herein shall have the meanings ascribed to such terms in the Agreement.
AMENDMENT NO. 1 TO OPEN MARKET SALE AGREEMENT May 5, 2021Open Market Sale Agreement • May 5th, 2021 • Sangamo Therapeutics, Inc • Biological products, (no disgnostic substances)
This Amendment No. 1 (“Amendment No. 1”) amends that certain Open Market Sale AgreementSM, dated as of August 5, 2020 (the “Agreement”), by and between Sangamo Therapeutics, Inc. (the “Company”) and Jefferies LLC, as sales agent and/or principal (the “Agent”). Defined terms used herein and not otherwise defined shall have the meaning assigned to such terms in the Agreement.
OPEN MARKET SALE AGREEMENTOpen Market Sale Agreement • December 1st, 2023 • Trinity Capital Inc. • New York
AMENDMENT NO. 1 TO OPEN MARKET SALE AGREEMENT November 1, 2012Open Market Sale Agreement • November 1st, 2012 • Gladstone Commercial Corp • Lessors of real property, nec
This Amendment No. 1 (“Amendment No. 1”) amends that certain Open Market Sale Agreement, dated as of November 4, 2009 (the “Agreement”), by and among Gladstone Commercial Corporation (the “Company”), Gladstone Commercial Limited Partnership (the “Operating Partnership”) and Jefferies & Company, Inc., as sales agent and/or principal (the “Agent”). Defined terms used herein and not otherwise defined shall have the meaning assigned to such terms in the Agreement.
OPEN MARKET SALE AGREEMENTOpen Market Sale Agreement • August 8th, 2023 • Postal Realty Trust, Inc. • Real estate investment trusts
Reference is made to that certain Open Market Sale Agreement (the “Agreement”), dated as of November 4, 2022, by and between Postal Realty Trust, Inc. (the “Company”), Postal Realty LP (the “Operating Partnership”) and [BANK] (the “Sales Agent”). Capitalized terms used but not defined herein shall have the meanings ascribed to such terms in the Agreement.
AMENDMENT NO. 2 TO OPEN MARKET SALE AGREEMENT March 3, 2022Open Market Sale Agreement • March 3rd, 2022 • Wave Life Sciences Ltd. • Pharmaceutical preparations
This Amendment No. 2 (“Amendment No. 2”) amends that certain Open Market Sale AgreementSM, dated as of May 10, 2019, as amended by Amendment No. 1, dated as of March 2, 2020 (together, the “Agreement”), by and between Wave Life Sciences Ltd. (the “Company”) and Jefferies LLC, as sales agent and/or principal (the “Agent”). Defined terms used herein and not otherwise defined shall have the meaning assigned to such terms in the Agreement.
AMENDMENT NO. 1 TO OPEN MARKET SALE AGREEMENT November 19, 2021Open Market Sale Agreement • November 19th, 2021 • Abeona Therapeutics Inc. • Pharmaceutical preparations
This Amendment No. 1 (“Amendment No. 1”) amends that certain Open Market Sale Agreement, dated as of August 17, 2018 (the “Agreement”), by and between Abeona Therapeutics Inc. (the “Company”) and Jefferies LLC (the “Agent”). Defined terms used herein and not otherwise defined shall have the meaning assigned to such terms in the Agreement.
AMENDMENT NO. 1 TO OPEN MARKET SALE AGREEMENT May 31, 2023Open Market Sale Agreement • June 1st, 2023 • Corbus Pharmaceuticals Holdings, Inc. • Pharmaceutical preparations
This Amendment No. 1 (“Amendment No. 1”) amends that certain Open Market Sale Agreement, dated as of August 6, 2020 (the “Agreement”), by and between Corbus Pharmaceuticals Holdings, Inc. (the “Company”) and Jefferies LLC (the “Agent”). Defined terms used herein and not otherwise defined shall have the meaning assigned to such terms in the Agreement.
OPEN MARKET SALE AGREEMENTOpen Market Sale Agreement • March 22nd, 2024 • Adicet Bio, Inc. • Pharmaceutical preparations • New York
Adicet Bio, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell from time to time through Jefferies LLC, as sales agent and/or principal (the “Agent”), shares of the Company’s common stock, par value $0.0001 per share (the “Common Shares”), on the terms set forth in this agreement (this “Agreement”).
OPEN MARKET SALE AGREEMENTOpen Market Sale Agreement • August 9th, 2023 • Vaxxinity, Inc. • Pharmaceutical preparations
